equityflowunderstand the flow and follow it
EquityFlow › Companies › Hoba Therapeutics

Hoba Therapeutics

Biotech · Copenhagen, DK

Non-opioid therapeutic proteins for chronic neuropathic pain and hearing loss

In the network

Shares the most investors with (number = shared investors):
Freya Biosciences 2HPNow 2REDUCED 2

Funding history

DateRoundAmount
Dec 2023Series A
Copenhagen biotech Hoba Therapeutics raised a 23M EUR Series A led by Indaco Venture Partners and Medical Incubator Japan to advance its non-opioid pain drug HB-086.
$24.8M

Investors

Tap an investor to see what else they have backed.

EIC FundEir VenturesExport and Investment Fund of DenmarkIndaco Venture PartnersMedical Incubator JapanNovo Holdings

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in DK

ReelEveryday^LeafBlinkTrollGetWhySNIPR BiomeJoe & the JuiceHymethVentriJectGrand PMSDropla TechCellugy

Other companies at Series A stage

&Done&Open011h01Health1000 Satellites100ms11x.ai12 Pharmacy180° Seguros1X Technologies1k Kirana Bazaar207
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.